CHÉOS Scientists were successful in several CIHR funding competitions, announced in March.
Drs. Skye Barbic and Steve Mathias will lead a team of researchers that will study how youth engagement can help investigators better measure and understand youth mental health in Canada. The funding for this study is through the Patient-Oriented Collaboration Grant program.
Two groups of CHÉOS Scientists received funding through the SPOR Innovative Clinical Trial (iCT) Rewarding Success Development Grant program. Drs. Jagbir Gill and Adeera Levin are principal investigators in a study that will focus on improving access to kidney transplantation in rural, remote, and Indigenous communities in B.C.
Dr. Eric Grafstein will join a group of researchers from institutions across B.C., including UBC, C2E2, and the Ministry of Health, to implement and evaluate ActionADE, a software application designed to communicate adverse drug events across health sectors.
After successfully securing operating grants through the Opioid Crisis Knowledge Synthesis competition, CHÉOS Scientists Drs. Eugenia Oviedo-Joekes and Michael Krausz look to examine and mobilize knowledge around opioid dependency and mortality. Dr. Oviedo-Joekes, with Dr. Martin Schechter serving as a co-investigator, will conduct a review of patient-centered care in addictions treatment. Dr. Krausz, along with Dr. Christian Schütz, will generate a number of recommendations for the implementation of e-health interventions to decrease deaths due to opioid overdose.
For more information about the spring announcements, see the CIHR March funding decisions.
